What's New
Prescriber Update 47(3) September 2026
We've published the latest issue of Prescriber Update.
This issue contains information about cystic fibrosis transmembrane conductance regulator (CFTR) modulators, dose considerations for rosuvastatin, alpha-gal syndrome, and more.
News and Events
| Date | Type | Title |
|---|---|---|
| 3/9/2026 | Publications | Prescriber Update Vol. 47. No. 3 - September 2026 |
| 28/8/2026 | Notices | Updated Guidance on Clinical Trials Process for sponsors |
| 28/8/2026 | Consultation | Outcome of the consultation on proposed changes to the classification of vitamin D pursuant to the Medicines Regulations 1984 |
| 28/8/2026 | Committees | Medicines Adverse Reactions Committee - vacancies for specialist clinicians |
| 24/8/2026 | Consultation | Outcome of the consultation on changes to clozapine blood monitoring and prescribing requirements |
| 24/8/2026 | Committees | Agenda for the 76th Medicines Classification Committee meeting |
| 24/8/2026 | Committees | Medicines Classification Committee - Dates and Deadlines |
| 4/8/2026 | Notices | Update to guideline to include extension of the types of medicine labels eligible for a general labelling exemption |
